|  Help  |  About  |  Contact Us

Publication : Bigenic Cre/loxP, puDeltatk conditional genetic ablation.

First Author  Chen YT Year  2004
Journal  Nucleic Acids Res Volume  32
Issue  20 Pages  e161
PubMed ID  15561996 Mgi Jnum  J:99258
Mgi Id  MGI:3581764 Doi  10.1093/nar/gnh158
Citation  Chen YT, et al. (2004) Bigenic Cre/loxP, puDeltatk conditional genetic ablation. Nucleic Acids Res 32(20):e161
abstractText  Genetic ablation experiments are used to resolve problems regarding cell lineages and the in vivo function of certain groups of cells. We describe a two-component conditional ablation technology using a mouse carrying an X-linked puDeltatk transgene, which is only activated in cells expressing Cre. Ablation of the Cre-expressing cells can be temporally regulated by the time of ganciclovir (GCV) administration. This strategy was demonstrated using a Col2Cre transgenic line. Differentiating chondrocytes in bigenic animals could be ablated at different developmental stages resulting in disorganized growth plates and dwarfism. Macrocephaly, macroglossia and umbilical hernia were also observed in ablated 18.5 dpc embryos. Crosses between the puDeltatk selector transgenic line and existing cre lines will facilitate numerous temporally regulated tissue-specific ablation experiments.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression